Carcinome médullaire rénal SMARCB1-déficient révélé par une métastase ganglionnaire sus-claviculaire
- 29 May 2024
- journal article
- research article
- Published by Elsevier in Annales de Pathologie
- Vol. 44 (5) , 372-377
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 casesLaboratory Investigation, 2019
- Renal Medullary CarcinomaArchives of Pathology & Laboratory Medicine, 2019
- Renal Medullary Carcinoma: a Report of the Current LiteratureCurrent Urology Reports, 2019
- SMARCB1-deficient Tumors of Childhood: A Practical GuidePediatric and Developmental Pathology, 2017
- Genomic Characterization of Renal Medullary Carcinoma and Treatment OutcomesClinical Genitourinary Cancer, 2017
- Renal Medullary Carcinoma: Establishing Standards in PracticeJournal of Oncology Practice, 2017
- Renal medullary carcinoma and sickle cell trait: A systematic reviewPediatric Blood & Cancer, 2015
- Renal Medullary CarcinomaAmerican Journal of Surgical Pathology, 2013
- Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behaviorLaboratory Investigation, 2008